Droia Ventures ^Investors

Droia Ventures is a specialist investor based in Luxembourg, Luxembourg. Founded in 2011, Droia is exclusively focused on the development of oncology and genetic disease therapies. The investor operates primarily in the European Union (EU), Europe, Middle East, and Africa (EMEA) regions. Droia Ventures has made significant investments in the biotech, pharma, and Biomed sectors, with notable companies in its portfolio including Frontier Medicines. With its strategic focus on cutting-edge therapies, Droia Ventures plays a crucial role in advancing innovative solutions for the treatment of cancer and genetic diseases.